Headlines Point to Continued Pressure on Pharmacy
Marsha K. Millonig, B.Pharm., M.B.A.
My plan for this year’s inaugural column was to provide insights and highlights from IQVIA’s recent five-year industry outlook. Instead, several headlines have caused me to pause and reflect on how my pharmacy colleagues are doing as 2022 unfolds. It started yesterday, with an e-newsletter that drew at…
Keep reading with a 7-day free trial
Subscribe to Pharmacy Technology & Management Review to keep reading this post and get 7 days of free access to the full post archives.